Aarogya Setu
A mobile application developed by the Government of India for contact tracing and health services related to COVID-19.
Aarogya Setu is a mobile application developed by the Government of India to connect essential health services with the people of India in the combined fight against COVID-19. The app is aimed at augmenting the initiatives of the government, particularly the Department of Health and Family Welfare and the Ministry of Health and Family Welfare, in proactively reaching out to and informing the users of the app regarding risks, best practices, and relevant advisories pertaining to the containment of COVID-19.
Development and Launch
Aarogya Setu was developed by the National Informatics Centre under the Ministry of Electronics and Information Technology. The app was launched on April 2, 2020, and quickly became one of the most downloaded apps in India, with millions of users registering within the first few days of its release.
Features
The app uses Bluetooth and GPS technology to track the interaction of users with others who have tested positive for COVID-19. It provides information on the risk of infection based on the user's location and interactions. The app also offers self-assessment tests, updates on COVID-19 cases, and information on nearby testing centers.
Contact Tracing
Aarogya Setu uses Bluetooth-based contact tracing to identify users who have come in close proximity to someone who has tested positive for COVID-19. If a user is found to be at risk, the app alerts them and provides guidance on the next steps, such as self-isolation or testing.
Self-Assessment
The app includes a self-assessment tool that allows users to evaluate their symptoms and determine their risk of having contracted COVID-19. Based on the responses, the app provides recommendations and guidance.
Information and Updates
Aarogya Setu provides users with the latest updates on COVID-19, including statistics on the number of cases, recoveries, and deaths. It also offers information on government advisories and safety measures.
Privacy and Data Security
The app has been subject to scrutiny regarding privacy and data security. The government has assured users that the data collected is encrypted and stored securely, and that it is only used for the purpose of contact tracing and health services.
Impact and Reception
Aarogya Setu has been widely used across India and has played a significant role in the country's efforts to manage the spread of COVID-19. However, it has also faced criticism from privacy advocates and some sections of the public.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
